𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gd-EOB-DTPA enhancement pattern of hepatocellular carcinomas in rats: Comparison with Tc-99m-IDA uptake

✍ Scribed by Bernard E. van Beers; Cécile Grandin; Stanislas Pauwels; Isabelle Mottet; Jean-François Goudemant; Monique Delos; Roger Demeure; Jacques Pringot


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
453 KB
Volume
4
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The enhancement pattern of chemically induced hepatocellular carcinomas (HCCs) after intravenous administration of the hepatobiliary magnetic resonance (MR) contrast agent gadolinium‐EOB‐DTPA (ethoxybenzyl‐diethylenetriaminepentaacetic acid) was compared with the uptake pattern of technetium‐99m‐labeled iminodiacetic acid (IDA), a hepatobiliary radioactive tracer. The hepatocyte uptake of both the contrast agent and the scintigraphic agent has been shown to be driven by the organic anion transporter. The tumors enhanced less than the liver after Gd‐EOB‐DTPA administration, whereas the Tc‐99m‐IDA uptake of differentiated HCCs exceeded that of the liver at 30 minutes and 3 hours after administration. The enhancement pattern of a differentiated HCC with Gd‐EOB‐DTPA does not mirror that seen with Tc‐99m‐IDA.


📜 SIMILAR VOLUMES


Comparison between areas with Gd-EOB-DTP
✍ Sanghee Lee; Seong Hyun Kim; Cheol Keun Park; Young-sun Kim; Won Jae Lee; Hyo K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

## Abstract ## Purpose: To determine histological and MR imaging differences between areas with Gd‐EOB‐DTPA (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) uptake and without in hepatocellular carcinomas (HCCs) as seen on Gd‐EOB‐DTPA‐enhanced hepatobiliary‐phase MR images. ## Materi

Contrast enhancement with GD-EOB-DTPA in
✍ Makoto Fujita; Reiko Yamamoto; Bernhard Fritz-Zieroth; Tsuyoshi Yamanaka; Masaya 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

## Abstract The purpose of this study was to evaluate the ability of the new liver‐specific magnetic resonance contrast agent gadolinium‐ethoxybenzyl‐diethylenetriamine penta‐acetic acid (Gd‐EOB‐DTPA) to detect hepatocellular carcinoma (HCC). Seventeen mice with 66 chemically induced HCCs underwent